Article Text

Download PDFPDF

IgA vasculitis in adults: few certainties and many uncertainties
  1. Alojzija Hočevar1,2,
  2. Matija Tomšič1,2,
  3. Žiga Rotar1
  1. 1 Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia
  2. 2 Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
  1. Correspondence to Dr Alojzija Hočevar, Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana 1000, Slovenia; alojzija.hocevar{at}gmail.com

Statistics from Altmetric.com

We read with great interest the article on cardiovascular, thromboembolic and renal outcomes in patients with immunoglobulin A vasculitis (IgAV), published recently online in A nnals of the R heumatic D iseases.1

Tracy et al, estimated both a childhood and an adult onset of IgAV incidence rates and reported an increased risk of hypertension and chronic kidney disease in patients with IgAV, compared with age-matched and sex-matched controls based on retrospective data over a 12-year period extracted from a primary care database in the UK. They estimated the incidence rate of adult IgAV at 2.2 per 100 000 person-years,1 which is close to the historic belief that IgAV rarely affects adults but was …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles